#VisualAbstract: Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma
Bookmark Click to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine, Inc....
Read MoreOct 28, 2023
Bookmark Click to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine, Inc....
Read MoreOct 28, 2023
Bookmark Click to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine,...
Read MoreOct 27, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreOct 26, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreOct 26, 2023
Bookmark1. This single-blinded, phase 2 randomized clinical trial found that intraventricular...
Read MoreOct 21, 2023
Bookmark Click to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine, Inc....
Read MoreOct 21, 2023
Bookmark1. In this randomized controlled trial, early compared to late blood pressure management...
Read MoreOct 20, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreOct 20, 2023
Bookmark Click to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine,...
Read MoreOct 18, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreOct 14, 2023
Bookmark Click to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine,...
Read MoreOct 14, 2023
Bookmark 1. The 90-day modified Ranking Scale score was comparable for patients in intravenous...
Read MoreOct 14, 2023
Bookmark Click to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine,...
Read MoreOct 13, 2023
Bookmark1. In this randomized controlled trial, complete revascularization reduced the risk of...
Read MoreOct 12, 2023
Bookmark1. In this randomized controlled trial, prophylactic antibiotics resulted in significantly...
Read MoreOct 8, 2023
Bookmark Click to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine, Inc....
Read MoreOct 6, 2023
Bookmark1. 4-year event-free survival was significantly greater in I-SABR (77%) versus SABR alone...
Read MoreOct 6, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreOct 6, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreOct 6, 2023
BookmarkClick to read this study in NEJM. VA design by Bryan Sun. ©2023 2 Minute Medicine, Inc....
Read More